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t(2;11)(p21;q23) G- banding (left) - Courtesy Eric Crawford, and R- banding (Editor). 
 
Clinics and pathology 
Disease 
Myelodysplastic syndromes (MDS), acute non 
lymphocytic leukemia (ANLL) and acute 
lymphoblastic leukemia (ALL). 
Phenotype/cell stem origin 
20 cases were documented, 14 of them were MDS; in 
three cases, type of MDS was not described; the 
remaining cases were: 2 AISA, 5 RA and 4 RAEB; in 6 
patients, MDS has transformed into ANLL (M1, M5a, 
M6 and unidentified); in 6 cases acute leukemia was 
diagnosed: 4 ANLL, 2 ALL; ANLL FAB-types were: 
M0 evolving into M4, M1, M2 and atypical M3. 
Epidemiology 
Male predominance: 13 M:7 F; the majority of patients 
(16 out of 20) were over 50 years of age and 8 of them 




Due to heterogeneity of cases and lack of molecular 
data, the prognostic importance of t(2;11)(p21;q23)  
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cannot be assessed; in 6 cases of MDS transformation 
into ANLL, MDS phase varied from 18 months to 5 
years; in 4 out of 5 ANLL cases treated in 1986-1993, 
remission duration varied from 6 to 13 months. 
Cytogenetics 
Cytogenetics morphological 
A high variability of breakpoints on both chromosome 
2 (2p16-2p21) and chromosome 11 (11q13-11q25) 
were found by conventional cytogenetics. 
Cytogenetics molecular 
MLL gene involvement was observed in 2 out of 3 
cases studied. 
Additional anomalies 
Additional abnormalities were observed in 10 out of 20 
cases; in 8 cases, del(5)(q13q33) is found; it is of note, 
that deletions of 5q usually are not seen in cases with 
MLL-associated translocations. 
Genes involved and proteins 
Note 





37 exons, spanning about 120 kb; 13-15 mRNA. 
Protein 
431 kD; transcriptional regulatory factor, nuclear 
localization; Contains two DNA binding motifs (a AT 
hook and zinc fingers), a DNA methyl transferase 
motif. 
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